Drug Type Peptide Conjugate Radionuclide, Therapeutic radiopharmaceuticals |
Synonyms 177Lu-PD 32766, 177Lu-PD32766 |
Target |
Action modulators |
Mechanism CAIX modulators(Carbonic anhydrase IX modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Locally Advanced Clear Cell Renal Cell Carcinoma | Preclinical | Japan | 22 Mar 2024 |





